| Literature DB >> 30709510 |
John Choi1, Albana Bano1, Jamil Azzi2.
Abstract
After more than 6 decades of clinical practice, the transplant community continues to research noninvasive biomarkers of solid organ injury to help improve patient care. In this review, we discuss the clinical usefulness of selective biomarkers and how they are processed at the laboratory. In addition, we organize these biomarkers based on specific aims and introduce innovative markers currently under investigation.Entities:
Keywords: Allograft; Biomarker; Rejection; Transplant; Transplant immunology
Mesh:
Substances:
Year: 2018 PMID: 30709510 PMCID: PMC6469386 DOI: 10.1016/j.cll.2018.11.003
Source DB: PubMed Journal: Clin Lab Med ISSN: 0272-2712 Impact factor: 1.935